Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Improving peptide synthesis and overcoming synthesis challenges remain big topics for discussion within the ever-evolving pharma/biotech industry. Gyros Protein Technologies are one such company at the forefront of peptide synthesis and bioanalysis, enabling...
Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Hot Melt Extrusion continues to be a fast growing technology in the pharm/biotech industry as a novel technique to solve difficult formulation challenges, primarily in the area of solubilization. One of the leading companies in HME technology is contract research and...
Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
In an ever evolving and ever changing landscape, preclinical formulation is an exciting area for drug product development. Formulation design is especially important in poorly bioavailable clinical candidates. To give meaningful results, the compound has to be...
Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Establishing PK biocomparability continues to be an important challenge for the pharmaceutical and biotech industry. Overcoming the challenges within biologic therapeutics have led to many innovative bioanalytical approaches. One such approach was using a monoclonal...
Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
One of our partners, ‘Quotient Sciences’ is dedicated to accelerating the development of new drugs for patients around the world, providing CRO and CDMO services including formulation development, clinical pharmacology trials, and clinical and commercial...
Recent Comments